This paper describes a case where a patient developed Candida esophagitis (a fungal infection in the esophagus) while being treated with mycophenolate mofetil (MMF) for atopic dermatitis. This appears to be the first reported case of this side effect in patients treated with MMF.
-
Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis.
Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis.
Anna Kurayev, Alice B Gottlieb
Case Reports
•
1 participants
•
2016
•
0 citations
Key insights related to Cellcept from this study:
-
What is this paper about?
-
How did the authors study this?
The authors presented a single case report, documenting the patient's symptoms, medical history, and diagnostic procedures including an esophagogastroduodenoscopy (EGD) with biopsy.
-
What populations did the authors study?
The study focused on a single 59-year-old Caucasian female patient with long-standing atopic dermatitis who had been treated with MMF for 22 months.
-
What conclusions can we draw?
While MMF is generally considered a safe medication with good effectiveness for inflammatory skin conditions, doctors should be aware that Candida esophagitis can occur as a rare complication. The authors note that recognizing this potential side effect is important for timely treatment.
Did this article interest you?
As a member of the Lemma Health community, you'll stay up to date with research, hear about new products, and get exclusive access to discounts.
Ready for better skin health?
At Lemma Health, we provide evidence-based skin care. Access providers in all 50 states. Receive your medications delivered.
Eczema is more than skin deep
Join our waitlist while we set up personalized holistic eczema care.